当前位置:首页 - 行情中心 - 东亚药业(605177) - 财务分析 - 现金流量表

东亚药业

(605177)

  

流通市值:29.39亿  总市值:29.66亿
流通股本:1.14亿   总股本:1.15亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金346,215,522.64176,413,185.57653,293,092.1454,908,438.63
  收到的税费返还5,535,894.65,535,894.656,074,573.6353,106,520.27
  收到其他与经营活动有关的现金8,503,341.144,550,388.5341,907,041.5415,504,734.44
  经营活动现金流入小计360,254,758.38186,499,468.7751,274,707.27523,519,693.34
  购买商品、接受劳务支付的现金126,736,366.8354,331,715.82723,297,732.96563,822,707.12
  支付给职工以及为职工支付的现金105,993,429.6957,659,661.14201,028,541.02154,073,914.85
  支付的各项税费52,298,122.3831,723,796.8232,700,571.6419,130,805.97
  支付其他与经营活动有关的现金23,412,846.3210,650,356.7463,103,857.6139,218,350.82
  经营活动现金流出小计308,440,765.22154,365,530.521,020,130,703.23776,245,778.76
  经营活动产生的现金流量净额51,813,993.1632,133,938.18-268,855,995.96-252,726,085.42
二、投资活动产生的现金流量:
  收回投资收到的现金347,400,166.67130,000,000861,082,507.23385,700,000
  取得投资收益收到的现金3,291,309.16524,137.153,320,236.551,970,977.31
  处置固定资产、无形资产和其他长期资产收回的现金净额5,123,374.641,117,509.421,438,491.4868,612.03
  收到的其他与投资活动有关的现金---104,802.75
  投资活动现金流入小计355,814,850.47131,641,646.57865,841,235.18388,644,392.09
  购建固定资产、无形资产和其他长期资产支付的现金16,265,028.756,983,543.9674,256,035.0464,041,760.87
  投资支付的现金288,450,00073,000,000927,900,000502,900,000
  投资活动现金流出小计304,715,028.7579,983,543.961,002,156,035.04566,941,760.87
  投资活动产生的现金流量净额51,099,821.7251,658,102.61-136,314,799.86-178,297,368.78
三、筹资活动产生的现金流量:
  取得借款收到的现金41,700,00019,800,000358,980,000317,280,000
  收到其他与筹资活动有关的现金--69,668,239.5944,955,739.59
  筹资活动现金流入小计41,700,00019,800,000428,648,239.59362,235,739.59
  偿还债务支付的现金128,500,00039,800,000155,780,000115,000,000
  分配股利、利润或偿付利息支付的现金3,469,448.941,812,815.38,614,092.56,699,584.68
  支付其他与筹资活动有关的现金791,566.7258,428.34104,571,864.0972,592,908.28
  筹资活动现金流出小计132,761,015.6641,671,243.64268,965,956.59194,292,492.96
  筹资活动产生的现金流量净额-91,061,015.66-21,871,243.64159,682,283167,943,246.63
四、汇率变动对现金及现金等价物的影响-790,630.77-347,708.981,128,906.781,186,642.01
五、现金及现金等价物净增加额11,062,168.4561,573,088.17-244,359,606.04-261,893,565.56
  加:期初现金及现金等价物余额243,966,360.23243,966,360.23488,325,966.27488,325,966.27
  期末现金及现金等价物余额255,028,528.68305,539,448.4243,966,360.23226,432,400.71
补充资料:
  净利润-118,376,942.74--82,432,149.13-
  资产减值准备71,298,798.49-44,115,906.92-
  固定资产和投资性房地产折旧89,630,245.23-149,003,507.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧89,630,245.23-149,003,507.72-
  无形资产摊销2,033,752.25-2,590,094.89-
  长期待摊费用摊销2,730,306.56-4,431,084.95-
  处置固定资产、无形资产和其他长期资产的损失-89,140.38-387,524.12-
  固定资产报废损失2,015,779.97-2,798,211.15-
  财务费用19,007,250.43-16,695,785.23-
  投资损失-2,166,952--2,934,751.91-
  递延所得税-14,121,065.68--18,080,952.41-
  其中:递延所得税资产减少-14,121,065.68--17,916,125.36-
    递延所得税负债增加---164,827.05-
  存货的减少51,368,081.42-133,270,572.33-
  经营性应收项目的减少-48,326,427.91--174,455,845.41-
  经营性应付项目的增加-7,530,437.98--361,361,504.17-
  其他6,226,194.93-13,541,572.52-
  不涉及现金收支的投资和筹资活动金额其他项目1,344,356.88---
  现金的期末余额255,028,528.68-243,966,360.23-
  减:现金的期初余额243,966,360.23-488,325,966.27-
  现金及现金等价物的净增加额11,062,168.45--244,359,606.04-
公告日期2026-08-312026-04-302026-04-232025-10-31
审计意见(境内)标准无保留意见
TOP↑